Effects of Zhenggan Huayu decoction ((sic)) combined with entecavir on gut microbiota in patients with chronic hepatitis B fibrosis

被引：0

作者：

Chen, Wenlin ^{[1
]}

Liang, Fang ^{[1
]}

Zhang, Yuncheng ^{[1
]}

Lv, Jinzhen ^{[1
]}

Yang, Daguo ^{[2
]}

机构：

[1] Beijing Univ Chinese Med, Shenzhen Hosp, Dept Liver Dis, Shenzhen 518172, Peoples R China

[2] Shenzhen Third Peoples Hosp, Dept Liver Dis, Guangdong 518112, Peoples R China

来源：

JOURNAL OF TRADITIONAL CHINESE MEDICINE | 2023年 / 43卷 / 03期

关键词：

hepatitis B; chronic; fibrosis; RNA; ribosomal; 16S; Zhenggan Huayu decoction; entecavir; gut microbiota; LIVER AXIS; MECHANISMS; CIRRHOSIS; RISK;

D O I：

10.19852/j.cnki.jtcm.20230208.002

中图分类号：

R [医药、卫生];

学科分类号：

10 ;

摘要：

OBJECTIVE: To evaluate the effects of Zhenggan Huayu decoction ((sic), ZGHY) combined with entecavir (ETV) on the gut microbiota in patients with chronic hepatitis B (CHB) fibrosis. METHODS: A total of 59 CHB-related fibrosis patients were enrolled and treated with ZGHY combined with ETV (ZGHY + ETV) and ETV alone. Fecal samples were collected from patients at weeks 0, 12, and 24 after treatment and gut microbiota were analyzed by 16S rRNA gene sequencing. RESULTS: Compared to the ETV group, microbiota diversity in the ZGHY + ETV group was increased after 24 weeks. Some potentially pathogenic bacteria, including Fusobacteriaceae spp., Acidaminococcus spp., and Erysipelotrichaceae spp. were reduced in the ZGHY + ETV group, while Eubacteriaceae spp., Lactococcus spp., and several other beneficial bacteria were increased. CONCLUSION: Decreases in pathogenic bacteria and increases in probiotics were not always observed in the Traditional Chinese Medicine (TCM) group (e.g., Rothia was abundant). As an adjuvant TCM formulation for ETV, ZGHY had a positive role in the treatment of CHB patients.

引用

页码：559 / 567

页数：9

共 44 条

[1] Alcohol, liver disease and the gut microbiota [J].

Bajaj, Jasmohan S. .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (04) :235-246

[2] Altered profile of human gut microbiome is associated with cirrhosis and its complications [J].

Bajaj, Jasmohan S. ;

Heuman, Douglas M. ;

Hylemon, Phillip B. ;

Sanyal, Arun J. ;

White, Melanie B. ;

Monteith, Pamela ;

Noble, Nicole A. ;

Unser, Ariel B. ;

Daita, Kalyani ;

Fisher, Andmorgan R. ;

Sikaroodi, Masoumeh ;

Gillevet, Patrick M. .

JOURNAL OF HEPATOLOGY, 2014, 60 (05) :940-947

[3] Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 [J].

Bolyen, Evan ;

Rideout, Jai Ram ;

Dillon, Matthew R. ;

Bokulich, NicholasA. ;

Abnet, Christian C. ;

Al-Ghalith, Gabriel A. ;

Alexander, Harriet ;

Alm, Eric J. ;

Arumugam, Manimozhiyan ;

Asnicar, Francesco ;

Bai, Yang ;

Bisanz, Jordan E. ;

Bittinger, Kyle ;

Brejnrod, Asker ;

Brislawn, Colin J. ;

Brown, C. Titus ;

Callahan, Benjamin J. ;

Caraballo-Rodriguez, Andres Mauricio ;

Chase, John ;

Cope, Emily K. ;

Da Silva, Ricardo ;

Diener, Christian ;

Dorrestein, Pieter C. ;

Douglas, Gavin M. ;

Durall, Daniel M. ;

Duvallet, Claire ;

Edwardson, Christian F. ;

Ernst, Madeleine ;

Estaki, Mehrbod ;

Fouquier, Jennifer ;

Gauglitz, Julia M. ;

Gibbons, Sean M. ;

Gibson, Deanna L. ;

Gonzalez, Antonio ;

Gorlick, Kestrel ;

Guo, Jiarong ;

Hillmann, Benjamin ;

Holmes, Susan ;

Holste, Hannes ;

Huttenhower, Curtis ;

Huttley, Gavin A. ;

Janssen, Stefan ;

Jarmusch, Alan K. ;

Jiang, Lingjing ;

Kaehler, Benjamin D. ;

Bin Kang, Kyo ;

Keefe, Christopher R. ;

Keim, Paul ;

Kelley, Scott T. ;

Knights, Dan .

NATURE BIOTECHNOLOGY, 2019, 37 (08) :852-857

[4] Fibrosis in chronic viral hepatitis [J].

Calvaruso, Vincenza ;

Craxi, Antonio .

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2011, 25 (02) :219-230

[5] Methodological challenges of performing meta-analyses to compare the risk of hepatocellular carcinoma between chronic hepatitis B treatments [J].

Choi, Won-Mook ;

Yip, Terry Cheuk-Fung ;

Lim, Young-Suk ;

Wong, Grace Lai-Hung ;

Kim, W. Ray .

JOURNAL OF HEPATOLOGY, 2022, 76 (01) :186-194

[6] Gut-liver axis: The impact of gut microbiota on non alcoholic fatty liver disease [J].

Compare, D. ;

Coccoli, P. ;

Rocco, A. ;

Nardone, O. M. ;

De Maria, S. ;

Carteni, M. ;

Nardone, G. .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (06) :471-476

[7] PICRUSt2 for prediction of metagenome functions [J].

Douglas, Gavin M. ;

Maffei, Vincent J. ;

Zaneveld, Jesse R. ;

Yurgel, Svetlana N. ;

Brown, James R. ;

Taylor, Christopher M. ;

Huttenhower, Curtis ;

Langille, Morgan G. I. .

NATURE BIOTECHNOLOGY, 2020, 38 (06) :685-688

[8] Gut microbiota in human metabolic health and disease [J].

Fan, Yong ;

Pedersen, Oluf .

NATURE REVIEWS MICROBIOLOGY, 2021, 19 (01) :55-71

[9] The Treatment-Naive Microbiome in New-Onset Crohn's Disease [J].

Gevers, Dirk ;

Kugathasan, Subra ;

Denson, Lee A. ;

Vazquez-Baeza, Yoshiki ;

Van Treuren, Will ;

Ren, Boyu ;

Schwager, Emma ;

Knights, Dan ;

Song, Se Jin ;

Yassour, Moran ;

Morgan, Xochitl C. ;

Kostic, Aleksandar D. ;

Luo, Chengwei ;

Gonzalez, Antonio ;

McDonald, Daniel ;

Haberman, Yael ;

Walters, Thomas ;

Baker, Susan ;

Rosh, Joel ;

Stephens, Michael ;

Heyman, Melvin ;

Markowitz, James ;

Baldassano, Robert ;

Griffiths, Anne ;

Sylvester, Francisco ;

Mack, David ;

Kim, Sandra ;

Crandall, Wallace ;

Hyams, Jeffrey ;

Huttenhower, Curtis ;

Knight, Rob ;

Xavier, Ramnik J. .

CELL HOST & MICROBE, 2014, 15 (03) :382-392

[10] Clinical efficacy and safety of traditional Chinese medicine Xiao Yao San in insomnia combined with anxiety [J].

Hu, Jing ;

Teng, Jing ;

Wang, Wanyu ;

Yang, Ni ;

Tian, Haoyu ;

Zhang, Wei ;

Peng, Xiangyu ;

Zhang, Jingyu .

MEDICINE, 2021, 100 (43) :E27608

← 1 2 3 4 5 →